These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy. Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928 [TBL] [Abstract][Full Text] [Related]
9. [Dispersion of QT interval in arterial hypertension with left ventricular hypertrophy]. Cavallini B; Perri V; Sali M Minerva Cardioangiol; 1996; 44(1-2):45-8. PubMed ID: 8767622 [TBL] [Abstract][Full Text] [Related]
10. The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation. Maeda K; Takagi M; Tatsumi H; Nakagawa E; Yoshiyama M Osaka City Med J; 2008 Jun; 54(1):11-9. PubMed ID: 18819261 [TBL] [Abstract][Full Text] [Related]
11. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences]. McKenna WJ; Kleinebenne A Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767 [TBL] [Abstract][Full Text] [Related]
12. Hypertrophic cardiomyopathy: electrical abnormalities detected by the extended-length ECG and their relation to syncope. Barletta G; Lazzeri C; Franchi F; Del Bene R; Michelucci A Int J Cardiol; 2004 Oct; 97(1):43-8. PubMed ID: 15336805 [TBL] [Abstract][Full Text] [Related]
13. The influence of atenolol and propafenone on QT interval dispersion in patients 3 months after myocardial infarction. Puljevic D; Smalcelj A; Durakovic Z; Goldner V Int J Clin Pharmacol Ther; 1997 Sep; 35(9):381-4. PubMed ID: 9314091 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Grimm W; Christ M; Bach J; Müller HH; Maisch B Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812 [TBL] [Abstract][Full Text] [Related]
15. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218 [TBL] [Abstract][Full Text] [Related]
16. [QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes]. Radman A; Murín J; Bulas J; Reptová A; Ravingerová T; Mikes P; Kozliková K; Ghanem W; Jaber J; Baqi L Vnitr Lek; 2003 Oct; 49(10):802-7. PubMed ID: 14682153 [TBL] [Abstract][Full Text] [Related]
17. Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events. Grimm W; Steder U; Menz V; Hoffmann J; Maisch B Clin Cardiol; 1997 Feb; 20(2):107-10. PubMed ID: 9034638 [TBL] [Abstract][Full Text] [Related]
18. QT duration and dispersion in patients with anomalous origins of coronary arteries. Kargin R; Pala S; Akçakoyun M; Esen O; Demirkiran A; Karapinar H; Rasulzada M; Bitigen A; Emiroglu Y; Ozdemir N Pacing Clin Electrophysiol; 2009 Sep; 32(9):1163-7. PubMed ID: 19719493 [TBL] [Abstract][Full Text] [Related]
19. Effect of obesity on P-wave dispersion and QT dispersion in women. Seyfeli E; Duru M; Kuvandik G; Kaya H; Yalcin F Int J Obes (Lond); 2006 Jun; 30(6):957-61. PubMed ID: 16432544 [TBL] [Abstract][Full Text] [Related]
20. [Effect of hemodialysis on QT dispersion in chronic uremia]. Lörincz I; Mátyus J; Zilahi Z; Kun C; Karányi Z; Kakuk G Orv Hetil; 1999 Jan; 140(1):15-9. PubMed ID: 9989107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]